Frontiers in Oncology
Overview
Frontiers in Oncology is a peer-reviewed journal dedicated to advancing knowledge and understanding in the field of oncology. It publishes high-quality research articles, reviews, and clinical studies that cover various aspects of cancer research, including etiology, diagnosis, treatment, and prevention. With a multidisciplinary approach, the journal aims to foster collaboration and innovation among researchers, clinicians, and scientists, ultimately contributing to the improvement of cancer care and patient outcomes.
Details
Details
Abbr.
Front Oncol
Start
2011
End
Continuing
e-ISSN
2234-943X
Country
Switzerland
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 1746
136
SJR / Ranks: 3387
1066
CiteScore / Ranks: 4778
5.20
JIF / Ranks: 1761
4.7
Recent Articles
1.
Zhang Y, Wei Y, Liu C, Yang M
Front Oncol
. 2025 Mar;
15:1508173.
PMID: 40083880
Objective: The incidence of cervical cancer has increased in recent years. The tumor microenvironment (TME) is the local biological environment involved in tumor occurrence and development. This study aimed to...
2.
Reeves D, Leffers K, Rao V
Front Oncol
. 2025 Mar;
15:1498817.
PMID: 40083879
Introduction: As the use of immune checkpoint inhibitors (ICIs) continues to expand, it is important to be mindful of rare but serious side effects such as myocarditis. Multiple analyses of...
3.
Lei J, Zhao W, He T, Huang H, Jian H, Zhang M, et al.
Front Oncol
. 2025 Mar;
15:1480790.
PMID: 40083878
Sarcomatoid urothelial carcinoma of the renal pelvis is an extremely rare malignant tumor with a high risk of recurrence and metastasis and a poor prognosis. This case reports a 61-year-old...
4.
Mastoi Q, Latif S, Brohi S, Ahmad J, Alqhatani A, Alshehri M, et al.
Front Oncol
. 2025 Mar;
15:1535478.
PMID: 40083877
Introduction: A brain tumor is a collection of abnormal cells in the brain that can become life-threatening due to its ability to spread. Therefore, a prompt and meticulous classification of...
5.
Wang Y, Li X, Yang H, Yin C, Wu Y, Chen X
Front Oncol
. 2025 Mar;
15:1561675.
PMID: 40083876
Purpose: We aimed to identify the clinical predictors of incidental prostate cancer (IPCa) after surgery for presumed benign prostatic hyperplasia (BPH). Methods: The literature was comprehensively searched using PubMed, Web...
6.
Meade A, Maguire A, Bryant J, Cullen D, Medipally D, White L, et al.
Front Oncol
. 2025 Mar;
15:1470431.
PMID: 40083875
Although significant advances in understanding the molecular drivers of acquired and inherited radiosensitivity have occurred in recent decades, a single analytical method which can detect and classify radiosensitivity remains elusive....
7.
Lai J, Li A, Zeng X, Liu J, Zhou L
Front Oncol
. 2025 Mar;
15:1428922.
PMID: 40083874
Purpose: To evaluate the dosimetric parameters and clinical outcomes of hypofractionated stereotactic radiotherapy (HSRT) for small brain metastases [BMs; planning target volume (PTV) ≤ 4 cm) via coplanar volumetric modulated...
8.
Wang X, Zhao X, Wang M
Front Oncol
. 2025 Mar;
15:1448753.
PMID: 40083873
Thymomas are rare malignancies originating from the epithelial cells of the thymus, typically presenting in the anterior mediastinum. Despite their indolent nature and slow growth, thymomas have the potential to...
9.
Tian Y, Budka J, Locke F, Westin J, To C, Tiwari G, et al.
Front Oncol
. 2025 Mar;
15:1519473.
PMID: 40083872
Introduction: CAR T cell therapy provided transformative outcomes for patients with B-cell lymphoma; however, a large fraction of patients remains at risk for relapse, underlying the need to uncover mechanisms...
10.
Shao W, Xue Y, Xu Z, Guan J, Wang H, Chen X, et al.
Front Oncol
. 2025 Mar;
15:1450054.
PMID: 40083871
Objective: To evaluate the impact of depth of cervical stromal invasion (CSI) on the prognosis of International Federation of Gynecology and Obstetrics (FIGO) stage II endometrioid endometrial cancer (EEC). Methods:...